Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rapikit is a diagnostics brand and business unit focused on rapid point-of-care test kits based on lateral flow immunochromatographic assays. The business appears to operate from Chandigarh, India and is described by third-party sources as a unit associated with Nectar Biosciences/Nectar Lifesciences. Its commercial menu includes rapid tests for pregnancy and ovulation as well as infectious disease assays for HIV, hepatitis B and C, malaria, dengue, syphilis, typhoid, and Zika, alongside selected cardiac and thyroid testing products. Rapikit also appears to provide private-label manufacturing services for rapid diagnostic kits. The company is best characterized as a commercial in-vitro diagnostics manufacturer rather than a therapeutic biotech or drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rapikit.